To determine the susceptibility profile of S. agalactiae isolated from vaginal cavity and perineal region from pregnant women in Medellín (Colombia)

Perfil de sensibilidad de S. agalactiae obtenido a partir de muestras de introito vaginal y región perineal de mujeres gestantes de Medellín (Colombia)

Published 2011-06-30

Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 9 No. 15 (2011)
Section
Artículo Original
How to Cite
Duque, C. M., Gómez, B., Sánchez, D. M., & Uribe, O. L. (2011). To determine the susceptibility profile of S. agalactiae isolated from vaginal cavity and perineal region from pregnant women in Medellín (Colombia). NOVA, 9(15). https://doi.org/10.22490/24629448.486
DOI

https://doi.org/10.22490/24629448.486
Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Clara María Duque
    Beatriz Gómez
      Diana Marcela Sánchez
        Olga Lucia Uribe
          Show authors biography
          We have carried out a descriptive study to determine the susceptibility profile of S. agalactiae isolates from the vaginal cavity and the perineal region from pregnant women in Medellín, between 2008 and 2010. The S. agalactiae isolates were obtained by first culturing samples in Todd Hewitt broth with antibiotics followed by sub-culturing in agar with Blood 5%. The Kirby-Bauer method described by the Clinical and Laboratory Standards Institute (CLSI) was used to evaluate the antimicrobial susceptibility profile of the isolates. A susceptibility of 100% to ampicillin and vancomycin was observed, that decreased to 25% for tetracycline and 72% for erythromycin and clindamycin.

          Article visits 214 | PDF visits 98

          Downloads

          Download data is not yet available.
          1. RajagopalL.Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 2009 Mar; 4(2):201-21.
          2. RJ, Baquero D. Frecuencia de aislamiento de Streptococcusagalactiaeen un grupo de embarazadas y sus productos. IATREIA. 1989;2:111-3.
          3. González CP, González JE. Prevalencia de estreptococo beta hemolítico en mujeres embarazadas de alto riesgo en el Hospital Simón Bolívar de Bogotá. UCIN. 2001;2:7-15.
          4. Miranda J, Sánchez I, Matar S. Detección de Streptococcusagalactiae en mujeres embarazadas del hospital San Jerónimo de Montería. InfQuincEpidemiolNac. 2002;7:
          5. Restrepo A, Serna L, Vanegas C, Sarria C, Durango H, Zapata C. Prevalencia de Streptococcusagalactiae en gestantes con factores de riesgo y sus recién nacidos. Hospital Universitario San Vicente de Paúl, 2002. Infectio. 2003;7:147-52.
          6. Duque CM, Gómez B, Uribe OI, et. al. Comparación de métodos para la recuperación y determinación de la prevalencia de Streptococcusagalactiae en mujeres gestantes de Medellín. Infectio. 2010; 14(2): 105-111
          7. Di Bartolomeo S., Gentile M., Priore G., Valle S., Di Bella A..Streptococcus agalactiae en embarazadas. 2005 , 37: 142-144.
          8. Clinical and Laboratory Standars Institute. Performance Standards for Antimicrobial Susceptibility Testing 2010. M100 - S20. Vol. 30 No. 1.
          9. Quiroga M, Pegels, Peryra, M. Vergara. Antibiotic susceptibility patterns and prevalence of Group B streptococcus isolated from pregnant women in Misiones, Argentina. Brazilian Journal of Microbiology (2008) 39: 245-250
          10. Abarzúa F, Arias A, García P y otros. Aumento de resistencia de Streptococcusagalactiae vaginal-anal en el tercer trimestre de gestación
          11. a eritromicina y clindamicina al cabo de una década de tamizaje universal. Rev Chil Infect 2011; 28 (4): 334-337
          12. Joachim A, Matee M I, Massawe F A, Lyamuya E F. Maternal and neonatal colonization of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health 2009; 9: 437.
          13. Wu H M, Janapatla R P, Ho Y R, Hung K H, Wu C W, Yan J J, et al. Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 2008; 52: 1888-90.
          14. Simoes JA, Aroutcheva AA, Heimler I, Faro S. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis ObstetGynecol 2004; 12: 1-8.
          15. González JJ, Andreu A. Susceptibility of vertically transmitted Group B streptococci to antimicrobial agents. Multicenterstudy. EnfermInfeccMicrobiolClin. 2004 May; 22(5):286-91.
          16. Valdes r, Enrique et al. Prevalencia de colonización por Streptococcus agalactiae(grupo B) durante el embarazo pesquisado en medio de cultivo selectivo. Rev. chil. obstet. ginecol. 2004, vol.69, n.2
          17. ViegasCaetano J y col. Detección y caracterización de Streptococcusagalactiae en muestras para urocultivo. ActaBioquímClínLatinoam 2004; 38 (4): 459-63
          18. Metsvaht T, Oselin K, Ilmoja ML, Anier K, Lutsar I .Pharmacokinetics of penicillin g in very-low-birth-weight neonates. Antimicrob Agents Chemother. 2007 Jun; 51(6):1995-2000.
          19. -------------------------------------------------------------------------------
          20. DOI: http://dx.doi.org/10.22490/24629448.486
          Tutorials

          Autors:

          How send article?

          Evaluator pair

          How to evaluate an article?

          Information

          Keywords

          Google Scholar profile

          Is part of
           
          Más leídos en los últimos 30 días

          Current Issue

          Sistema OJS 3.4.0.5 - Metabiblioteca |